These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 143102)

  • 1. [Functional state of the kidneys in experimental immune nephritis during the use of heparin, urokinase and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Urol Nefrol (Mosk); 1977; (4):23-5. PubMed ID: 143102
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [State of renal structure and function in nephrotoxic nephritis treated with uroplasmin].
    Monastyrskiĭ VA; Ambarova LI; Beshleĭ VI; Stasiuk NS
    Arkh Patol; 1978; 40(5):26-31. PubMed ID: 150828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
    Fujioka M
    Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of urokinase on renal structure and function in experimental immune nephritis].
    Monastyrskiĭ VA; Abramova LI; Stasiuk NS; Beshleĭ VI
    Patol Fiziol Eksp Ter; 1979; (4):65-6. PubMed ID: 481925
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expediency of the use of uroplasmin in clinical practice].
    Skipetrov VP; Potapkina N; Chernyshev V; Shuvalov V
    Vrach Delo; 1974 Jan; (1):48-50. PubMed ID: 4283231
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM; Simpson IJ; Peters DK
    Clin Exp Immunol; 1975 Feb; 19(2):301-8. PubMed ID: 1212801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic therapy with urokinase. Clinical trials].
    Bizzi B; Leone G; Tutinelli F; Landolfi R
    Clin Ter; 1978 Sep; 86(5):419-32. PubMed ID: 737966
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolytic therapy in myocardial infarction.
    Duckert F
    Prog Cardiovasc Dis; 1979; 21(5):342-50. PubMed ID: 154123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].
    Chiche P; Bénaim R; Samama M; Maury J
    Coeur Med Interne; 1978; 17(1):59-66. PubMed ID: 639489
    [No Abstract]   [Full Text] [Related]  

  • 12. [Letter: Thrombolytic treatment in subacute and chronic pulmonary arterial thrombosis].
    Chiche P; Benaim R; Acar J; Pouget P; Marien C; Samama M
    Nouv Presse Med; 1976 May; 5(22):1428-9. PubMed ID: 934866
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of microcirculatory disorders in cardiogenic shock].
    Dunchich LG; Stasiuk NS
    Vrach Delo; 1977 Nov; (11):57-61. PubMed ID: 595562
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urokinase treatment of threatened and acute myocardial infarct].
    Babeau P; Pras P
    Ann Med Interne (Paris); 1977 Feb; 128(2):219-25. PubMed ID: 869389
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombolytic therapy. Effect of urokinase on experimental thrombosis (author's transl)].
    Kakishita E
    Rinsho Ketsueki; 1977 Jun; 18(6):719-25. PubMed ID: 916202
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of thrombolytic therapy in venous thromboembolic disease.
    Rubin RN
    Conn Med; 1981 Sep; 45(9):551-4. PubMed ID: 7028391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment by urokinase of myocardial infarction and threatened infarction. Randomised study of 120 cases].
    Brochier M; Raynaud R; Planiol T; Fauchier JP; Griguer P; Archambaud D; Pellois A; Clisson M
    Arch Mal Coeur Vaiss; 1975 Jun; 68(6):563-9. PubMed ID: 810098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies on thrombolytic agents. (1) Comparison between prostaglandin E1, heparin and urokinase (author's transl)].
    Suzuki T; Takano S
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):890-6. PubMed ID: 735704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytics in venous thromboses of the retina].
    François P; Hochart G; Turut F; Delbecque H
    Bull Soc Ophtalmol Fr; 1976 Mar; 76(3):271-4. PubMed ID: 1024754
    [No Abstract]   [Full Text] [Related]  

  • 20. Arterial occlusion in a preterm infant. Successful non-surgical treatment with urokinase and low-dose heparin.
    Schmidt B; Wais U; Fürste HO; Pringsheim W
    Helv Paediatr Acta; 1982; 37(5):483-8. PubMed ID: 6761316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.